For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Control Arm | blood tested on healthy patients | None | None | 0 | 0 | 0 | 0 | View |
| Correlative | treated off study with or without oral deferasirox (patient choice) but lab draws to gather lab analysis | None | None | 0 | 0 | 0 | 0 | View |
| Arm I | Patients receive oral deferasirox once daily for up to 6 months or until blood counts recover in the absence of disease progression or unacceptable toxicity. deferasirox : Given orally laboratory biomarker analysis : Correlative studies enzyme-linked immunosorbent assay : Correlative studies | None | None | 4 | 4 | 4 | 4 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| hyperglycemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hyponatremia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hypokalemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| serum glutamic pyruvic transaminase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Thrombosis/thrombus/embolism | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Heartburn/dyspepsia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Confusion | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| "Distension bloating, abdominal" | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Infection Bladder | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Cystitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Lipase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Lymphopenia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Lung infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Infection Sinus | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Infection with normal ANC or Grade 1 or 2 neutrophils: Nose | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Low WBC | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| low Platelets | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Low Hemoglobin | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Anorexia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Gastrointestinal - Other | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Alkaline phosphatase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Creatinine | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Proteinuria | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Dyspnea | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Taste alteration | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dermatology/Skin | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Fatigue | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Weight loss | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| hyperglycemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hypoglycemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hypocalcemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hypomagnesemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hyponatremia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hypokalemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hypoalbuminemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hyperbilirubinemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| serum glutamic pyruvic transaminase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Pain: Head/headache | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| serum glutamic oxaloacetic transaminase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hypermagnesemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| hyperkalemia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Ocular/Visual - Other | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Urinary frequency/urgency | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Renal/Genitourinary - Other | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Cough | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Intra-operative Injury | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Musculoskeletal Soft Tissue - Other | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dry mouth | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dehydration | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pruritus/itching | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Rash/desquamation | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Pain: Abdomen | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Ataxia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Obstruction Bladder | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pain Bladder | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Amylase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Bronchospasm wheezing | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Urine color change | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Dry eye syndrome | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Anal Incontinence | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| gamma-Glutamyl transpeptidase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Glomerular filtration rate | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Lipase | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Lymphopenia | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Memory impairment | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pain: Muscle | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pain Oral cavity | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Pain: Extremity-limb | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Lung infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Allergic rhinitis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Hyperpigmentation | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Mucositis/stomatitis Oral cavity | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Tremor | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| blurred vision | SYSTEMATIC_ASSESSMENT | Eye disorders | None | View |
| Hemorrhage GU: Urinary | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Thrombosis/embolism (vascular access-related) | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Mucositis/stomatitis Oral cavity | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Infection Lip perioral | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Blood Infection with high grade neutropenia | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |